GPC2-CAR T Cell Therapy for Relapsed or Refractory Medulloblastoma in Children and Young Adults

Abroad (travel likely)RecruitingPHASE1

Conditions

Medulloblastoma · Central Nervous System Embryonal Tumor · Refractory Medulloblastoma · Recurrent Medulloblastoma · Pediatric Brain Tumor · Embryonal Tumor With Multilayered Rosettes (ETMR) · Pineoblastoma · Atypical Teratoid/Rhabdoid Tumor (ATRT) of the CNS · CNS Neuroblastoma · FOXR2-activated

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Lucile Packard Children's Hospital Stanford, Palo Alto, California, United States

    Contact: Study coordinator (Mariah Duncan) · GPC2CART@stanfordchildrens.org · 650-497-8953
    Contact: Principal Investigator (Katherine Ryan, DO)
    Sabine Heitzeneder, MD (Sub-investigator)
Study leads
  • Katherine Ryan, DO

    Principal Investigator

    Stanford University